Preventing congenital varicella syndrome with immunization

February 2011
CMAJ: Canadian Medical Association Journal;2/22/2011, Vol. 183 Issue 3, pE169
Academic Journal
The author discusses studies and case reports showing effective way on preventing congenital varicella syndrome in a seronegative mother through immunization. She is critical on studies in North America and Europe which confirmed that the incidence of congenital varicella syndrome in maternal varicella is 1% to 2%. She also relates case reports of the syndrome published in German and English literatures which serve as reminder to health professionals on counseling pregnant women with chickenpox.


Related Articles

  • PREVENTING THE POX.  // Time International (South Pacific Edition);3/1/2004, Issue 8, p62 

    The article reports on the findings of a study on how to prevent chicken-pox conducted by doctors in the U.S. It found that the ability of the chicken-pox vaccine to protect against the varicella virus turns weak after the first year. The vaccine is also ineffective in infants immunized before...

  • Varicella-Zoster Immune Globulin for the Prevention of Chickenpox.  // Annals of Internal Medicine;Jun84, Vol. 100 Issue 6, p859 

    Focuses on the statement issued by the Immunization Practices Advisory Committee on the use of varicella-zoster immune globulin (VZIG) in the U.S. Prevalence of chickenpox or varicella; List of immuncompromised persons; Prevention of chickenpox by VZIG; Determination of susceptibility to...

  • VARICELLA ZOSTER ANTIBODIES AMONG HEALTH CARE WORKERS IN A UNIVERSITY HOSPITAL, TEHERAN, IRAN. Talebi-Taher, Mahshid; Noori, Maria; Shamshiri, Ahmad-Reza; Barati, Mitra // International Journal of Occupational Medicine & Environmental H;Jan2010, Vol. 23 Issue 1, p27 

    Objectives: This study was designed to evaluate the immune status of health care workers against varicella zoster in a university hospital in Teheran, Iran, and to compare the history of chickenpox infection with the presence of varicella antibodies in this population. Methods: Serologic testing...

  • Varicella Vaccine Exposure during Pregnancy Data from 10 Years of the Pregnancy Registry. Wilson, Eileen; Goss, Mary Ann; Marin, Mona; Shields, Kristine E.; Seward, Jane F.; Rasmussen, Sonja A.; Sharrar, Robert G. // Journal of Infectious Diseases;Mar2008 Supplement 2, Vol. 197, pS178 

    Background. The Pregnancy Registry for Varivax (Merck) was established to monitor for congenital varicella syndrome or other birth defects in the offspring of women who were exposed to varicella vaccine while pregnant. Methods. The registry receives voluntary reports from health care providers...

  • ACIP Recommendations for the Prevention of Varicella. Smith, Liz // American Family Physician;11/1/2007, Vol. 76 Issue 9, p1396 

    The article highlights the recommendations by the U.S. Advisory Committee on Immunization Practices for the prevention of varicella. It mentions that varicella is a major infectious disease caused by infection with the varicella zoster virus (VZV) in the upper respiratory tract that usually...

  • Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence. Cheong Soo Park; Dong Soo Kim; Ki Hwan Kim // Clinical & Experimental Vaccine Research;Jul2013, Vol. 2 Issue 2, p140 

    Purpose: There are different principles regarding varicella vaccination depending on social requirements. This study was performed to report a case of breakthrough chickenpox outbreak among a group of people in the healthcare center and also evaluate the seroprevalence of patients who have been...

  • PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT. NOBRE, Fernanda Aimée; da Silva GONZALEZ, Isabela Garrido; de MORAES-PINTO, Maria Isabel; COSTA-CARVALHO, Beatriz Tavares // Revista do Instituto de Medicina Tropical de Sao Paulo;Sep/Oct2015, Vol. 57 Issue 5, p455 

    We describe the case of an eight-year-old boy with X-linked agammaglobulinemia who developed mild varicella despite regular intravenous immunoglobulin (IVIG) therapy. He maintained protective antibody levels against varicella and the previous batches of IVIG that he received had adequate...

  • Varicella-Zoster Immune Globulin.  // Clinical Pediatrics;Sep1984, Vol. 23 Issue 9, p476 

    The article provides information on varicella-zoster immune globulin (VZIG), which has been produced and distributed in Massachusetts by the Massachusetts Public Health Biologic Laboratories since its licensure on February 1, 1981, and distributed elsewhere by the American Red Cross...

  • varicella-zoster immunoglobulin.  // Royal Society of Medicine: Medicines;2002, p558 

    This article provides information on varicella-zoster immunoglobulin. This is a form of immunoglobulin that is used in immunization to give immediate passive immunity against infection by the varicella-zoster virus, but is used only in immunosuppressed patients at risk, neonates whose mothers...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics